José Manuel López Vega
Marqués de Valdecilla University Hospital(ES)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, SARS-CoV-2 and COVID-19 Research, Viral Infections and Immunology Research, Animal Virus Infections Studies, Chemotherapy-related skin toxicity
Most-Cited Works
- → Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer(2010)208 cited
- → Carboplatin: an active drug in metastatic breast cancer.(1992)78 cited
- → Intravenous and Oral Magnesium Supplementations in the Prophylaxis of Cisplatin-Induced Hypomagnesemia(1992)52 cited
- → Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide(2022)30 cited
- Phase II study of carboplatin in advanced breast cancer: preliminary results.(1991)
- → Analysis of the changes induced by bevacizumab using a high temporal resolution DCE-MRI as prognostic factors for response to further neoadjuvant chemotherapy(2014)13 cited
- → Central venous brachial catheter (P.A.S. port TM) and catheter scanning system (cath‐finder TM)(1994)11 cited
- → Myocarditis After mRNA-1273 Vaccination: A Population-Based Analysis of 151 Million Vaccine Recipients Worldwide(2021)10 cited
- → Análisis farmacoeconómico del tratamiento de la deficiencia de hierro con hierro carboximaltosa (Ferinject®) en España(2010)6 cited
- Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy.(2012)